A substantial body of literature has provided evidence that type 2 diabetes mellitus (T2DM) and colorectal neoplasia share several common factors. Both diseases are among the leading causes of death worldwide and have an increasing incidence. In addition to usual risk factors such as sedentary lifestyle, obesity, and family history, common pathophysiological mechanisms involved in the development of these diseases have been identified. These include changes in glucose metabolism associated with adipose tissue dysfunction including insulin resistance resulting to hyperinsulinemia and chronic hyperglycemia. In addition to altered glucose metabolism, abdominal obesity has been associated with accented carcinogenesis with chronic subclinical inflammation. An increasing number of studies have recently described the role of the gut microbiota in metabolic diseases including T2DM and the development of colorectal cancer (CRC). Due to the interconnectedness of different pathophysiological processes, it is not entirely clear which factor is crucial in the development of carcinogenesis in patients with T2DM. The aim of this work is to review the current knowledge on the pathophysiological mechanisms of colorectal neoplasia development in individuals with T2DM. Here, we review the potential pathophysiological processes involved in the onset and progression of colorectal neoplasia in patients with T2DM. Uncovering common pathophysiological characteristics is essential for understanding the nature of these diseases and may lead to effective treatment and prevention.

Department of Internal Medicine 1st Faculty of Medicine Charles University Military University Hospital Prague Czech Republic

Zobrazit více v PubMed

AGUILAR-CAZARES D, CHAVEZ-DOMINGUEZ R, CARLOS-REYES A, LOPEZ-CAMARILLO C, HERNADEZ DE LA CRUZ ON, LOPEZ-GONZALEZ JS. Contribution of angiogenesis to inflammation and cancer. Front Oncol. 2019;9:1399. doi: 10.3389/fonc.2019.01399. PubMed DOI PMC

AL-HADDAD R, KARNIB N, ASSAAD RA, BILEN Y, EMMANUEL N, GHANEM A, YOUNES J, ZIBARA V, STEPHAN JS, SLEIMAN SF. Epigenetic changes in diabetes. Neurosci Lett. 2016;625:64–69. doi: 10.1016/j.neulet.2016.04.046. PubMed DOI

AL-SHIBLI SM, HARUN N, ASHOUR AE, MOHD KASMURI MHB, MIZAN S. Expression of leptin and leptin receptors in colorectal cancer-an immunohistochemical study. PeerJ. 2019;7:e7624. doi: 10.7717/peerj.7624. PubMed DOI PMC

ANCEY PB, CONTAT C, MEYLAN E. Glucose transporters in cancer - from tumor cells to the tumor microenvironment. FEBS J. 2018;285:2926–2943. doi: 10.1111/febs.14577. PubMed DOI

ASHKTORAB H, SOLEIMANI A, NICHOLS A, SODHI K, LAIYEMO AO, NUNLEE-BLAND G, NOURAIE SM, BRIM H. Adiponectin, leptin, IGF-1, and tumor necrosis factor alpha as potential serum biomarkers for non-invasive diagnosis of colorectal adenoma in african americans. Front Endocrinol (Lausanne) 2018;9:77. doi: 10.3389/fendo.2018.00077. PubMed DOI PMC

AZIZIAN-FARSANI F, ABEDPOOR N, HASAN SHEIKHHA M, GURE AO, NASR-ESFAHANI MH, GHAEDI K. Receptor for advanced glycation end products acts as a fuel to colorectal cancer development. Front Oncol. 2020;10:552283. doi: 10.3389/fonc.2020.552283. PubMed DOI PMC

BAI Y, SUN Q. Macrophage recruitment in obese adipose tissue. Obes Rev. 2015;16:127–136. doi: 10.1111/obr.12242. PubMed DOI PMC

BELIZÁRIO JE, NAPOLITANO M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol. 2015;6:1050. doi: 10.3389/fmicb.2015.01050. PubMed DOI PMC

BHATTACHARYYA M, DAS M, BANDYOPADHYAY S. miRT: a database of validated transcription start sites of human microRNAs. Genomics Proteomics Bioinformatics. 2012;10:310–316. doi: 10.1016/j.gpb.2012.08.005. PubMed DOI PMC

BONGARZONE S, SAVICKAS V, LUZI F, GEE AD. Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A medicinal chemistry perspective. J Med Chem. 2017;60:7213–7232. doi: 10.1021/acs.jmedchem.7b00058. PubMed DOI PMC

BOOTH A, MAGNUSON A, FOUTS J, FOSTER MT. Adipose tissue: an endocrine organ playing a role in metabolic regulation. Horm Mol Biol Clin Investig. 2016;26:25–42. doi: 10.1515/hmbci-2015-0073. PubMed DOI

BURHANS MS, HAGMAN DK, KUZMA JN, SCHMIDT KA, KRATZ M. Contribution of adipose tissue inflammation to the development of type 2 Diabetes Mellitus. Compr Physiol. 2018;9:1–58. doi: 10.1002/cphy.c170040. PubMed DOI PMC

BUYSSCHAERT M, SADIKOT S. Diabetes and cancer: a 2013 synopsis. Diabetes Metab Syndr. 2013;7:247–250. doi: 10.1016/j.dsx.2013.08.001. PubMed DOI

CASTANEDA OA, LEE SC, HO CT, HUANG TC. Macrophages in oxidative stress and models to evaluate the antioxidant function of dietary natural compounds. J Food Drug Anal. 2017;25:111–118. doi: 10.1016/j.jfda.2016.11.006. PubMed DOI PMC

CASTELLARIN M, WARREN RL, FREEMAN JD, DREOLINI L, KRZYWINSKI M, STRAUSS J, BARNES R, WATSON P, ALLEN-VERCOE E, MOORE RA, HOLT RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299–306. doi: 10.1101/gr.126516.111. PubMed DOI PMC

CASTOLDI A, NAFFAH DE SOUZA C, CÂMARA NO, MORAES-VIEIRA PM. The Macrophage Switch in Obesity Development. Front Immunol. 2016;6:637. doi: 10.3389/fimmu.2015.00637. PubMed DOI PMC

CHANG SC, YANG WV. Hyperglycemia, tumorigenesis, and chronic inflammation. Crit Rev Oncol Hematol. 2016;108:146–153. doi: 10.1016/j.critrevonc.2016.11.003. PubMed DOI

CONCIATORI F, BAZZICHETTO C, FALCONE I, PILOTTO S, BRIA E, COGNETTI F, MILELLA M, CIUFFREDA L. Role of mTOR signaling in tumor microenvironment: an overview. Int J Mol Sci. 2018;19:2453. doi: 10.3390/ijms19082453. PubMed DOI PMC

COSIN-ROGER J, ORTIZ-MASIÀ MD, BARRACHINA MD. Macrophages as an emerging source of Wnt ligands: relevance in mucosal integrity. Front Immunol. 2019;10:2297. doi: 10.3389/fimmu.2019.02297. PubMed DOI PMC

DABKE K, HENDRICK G, DEVKOTA S. The gut microbiome and metabolic syndrome. J Clin Invest. 2019;129:4050–4057. doi: 10.1172/JCI129194. PubMed DOI PMC

DIVELLA R, DE LUCA R, ABBATE I, NAGLIERI E, DANIELE A. Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer. 2016;7:2346–2359. doi: 10.7150/jca.16884. PubMed DOI PMC

DONATO R, CANNON BR, SORCI G, RIUZZI F, HSU K, WEBER DJ, GECZY CL. Functions of S100 proteins. Curr Mol Med. 2013;13:24–57. doi: 10.2174/156652413804486214. PubMed DOI PMC

FERLAY J, COLOMBET M, SOERJOMATARAM I, MATHERS C, PARKIN DM, PIÑEROS M, ZNAOR A, BRAY F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–1953. doi: 10.1002/ijc.31937. PubMed DOI

FERNÁNDEZ-REAL JM, BROCH M, VENDRELL J, RICART W. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care. 2003;26:1362–1368. doi: 10.2337/diacare.26.5.1362. PubMed DOI

FLEGAL KM, CARROLL MD, KIT BK, OGDEN CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307:491–497. doi: 10.1001/jama.2012.39. PubMed DOI

FOUAD YA, AANEI C. Revisiting the hallmarks of cancer. Am J Cancer Res. 2017;7:1016–1036. PubMed PMC

FOURNIER PE, DRANCOURT M, COLSON P, ROLAIN JM, LA SCOLA B, RAOULT D. Modern clinical microbiology: new challenges and solutions. Nat Rev Microbiol. 2013;11:574–585. doi: 10.1038/nrmicro3068. PubMed DOI PMC

FRIXA T, DONZELLI S, BLANDINO G. Oncogenic microRNAs: key players in malignant transformation. Cancers (Basel) 2015;7:2466–2485. doi: 10.3390/cancers7040904. PubMed DOI PMC

GAMALLAT Y, MEYIAH A, KUUGBEE ED, HAGO AM, CHIWALA G, AWADASSEID A, BAMBA D, ZHANG X, SHANG X, LUO F, XIN Y. Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. Biomed Pharmacother. 2016;83:536–541. doi: 10.1016/j.biopha.2016.07.001. PubMed DOI

GIOULEME O, DIAMANTIDIS MD, KATSAROS MG. Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms. World J Gastroenterol. 2011;17:444–448. doi: 10.3748/wjg.v17.i4.444. PubMed DOI PMC

GONZÁLEZ N, PRIETO I, DEL PUERTO-NEVADO L, PORTAL-NUÑEZ S, ARDURA JA, CORTON M, FERNÁNDEZ-FERNÁNDEZ B, AGUILERA O, GOMEZ-GUERRERO C, MAS S, MORENO JA, RUIZ-ORTEGA M, SANZ AB, SANCHEZ-NIÑO MD, ROJO F, VIVANCO F, ESBRIT P, AYUSO C, ALVAREZ-LLAMAS G, EGIDO J, GARCÍA-FONCILLAS J, ORTIZ A. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications. Oncotarget. 2017;8:18456–18485. doi: 10.18632/oncotarget.14472. PubMed DOI PMC

GURAYA SY. Association of type 2 diabetes mellitus and the risk of colorectal cancer: A meta-analysis and systematic review. World J Gastroenterol. 2015;21:6026–6031. doi: 10.3748/wjg.v21.i19.6026. PubMed DOI PMC

GURUNG M, LI Z, YOU H, RODRIGUES R, JUMP DB, MORGUN A, SHULZHENKO N. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020;51:102590. doi: 10.1016/j.ebiom.2019.11.051. PubMed DOI PMC

HAO NB, LÜ MH, FAN YH, CAO YL, ZHANG ZR, YANG SM. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol. 2012;2012:948098. doi: 10.1155/2012/948098. PubMed DOI PMC

HOLLISTER EB, GAO C, VERSALOVIC J. Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology. 2014;146:1449–1458. doi: 10.1053/j.gastro.2014.01.052. PubMed DOI PMC

HOXHAJ G, MANNING BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20:74–88. doi: 10.1038/s41568-019-0216-7. PubMed DOI PMC

HUA H, KONG Q, YIN J, ZHANG J, JIANG Y. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy. J Hematol Oncol. 2020;13:64. doi: 10.1186/s13045-020-00904-3. PubMed DOI PMC

HUGON P, DUFOUR JC, COLSON P, FOURNIER PE, SALLAH K, RAOULT D. A comprehensive repertoire of prokaryotic species identified in human beings. Lancet Infect Dis. 2015;15:1211–1219. doi: 10.1016/S1473-3099(15)00293-5. PubMed DOI

HUMAN MICROBIOME PROJECT CONSORTIUM. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–214. doi: 10.1038/nature11234. PubMed DOI PMC

JIANG B. Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment. Genes Dis. 2017;4:25–27. doi: 10.1016/j.gendis.2017.02.003. PubMed DOI PMC

KASPRZAK A, ADAMEK A. Insulin-like Growth Factor 2 (IGF2) signaling in colorectal cancer-from basic research to potential clinical applications. Int J Mol Sci. 2019;20:4915. doi: 10.3390/ijms20194915. PubMed DOI PMC

KATIRA A, TAN PH. Evolving role of adiponectin in cancer-controversies and update. Cancer Biol Med. 2016;13:101–119. doi: 10.20892/j.issn.2095-3941.2015.0092. PubMed DOI PMC

KIM JH, BLOCK DE, MILLS DA. Simultaneous consumption of pentose and hexose sugars: an optimal microbial phenotype for efficient fermentation of lignocellulosic biomass. Appl Microbiol Biotechnol. 2010;88:1077–1085. doi: 10.1007/s00253-010-2839-1. PubMed DOI PMC

KOSTIC AD, GEVERS D, PEDAMALLU CS, MICHAUD M, DUKE F, EARL AM, OJESINA AI, JUNG J, BASS AJ, TABERNERO J, BASELGA J, LIU C, SHIVDASANI RA, OGINO S, BIRREN BW, HUTTENHOWER C, GARRETT WS, MEYERSON M. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22:292–298. doi: 10.1101/gr.126573.111. PubMed DOI PMC

LAGIER JC, EDOUARD S, PAGNIER I, MEDIANNIKOV O, DRANCOURT M, RAOULT D. Current and past strategies for bacterial culture in clinical microbiology. Clin Microbiol Rev. 2015;28:208–236. doi: 10.1128/CMR.00110-14. PubMed DOI PMC

MERCADO-PIMENTEL ME, ONYEAGUCHA BC, LI Q, PIMENTEL AC, JANDOVA J, NELSON MA. The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells. FEBS Lett. 2015;589:2388–2393. doi: 10.1016/j.febslet.2015.07.010. PubMed DOI PMC

MILOSEVIC VS, VUKMIROVIC FC, KRSTIC MS, ZINDOVIC MM, LJ STOJANOVIC D, JANCIC SA. Involvement of leptin receptors expression in proliferation and neoangiogenesis in colorectal carcinoma. J BUON. 2015;20:100–108. PubMed

MODZELEWSKA P, CHLUDZIŃSKA S, LEWKO J, RESZEĆ J. The influence of leptin on the process of carcinogenesis. Contemp Oncol (Pozn) 2019;23:63–68. doi: 10.5114/wo.2019.85877. PubMed DOI PMC

MOON HS, LIU X, NAGEL JM, CHAMBERLAND JP, DIAKOPOULOS KN, BRINKOETTER MT, HATZIAPOSTOLOU M, WU Y, ROBSON SC, ILIOPOULOS D, MANTZOROS CS. Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice. Gut. 2013;62:561–570. doi: 10.1136/gutjnl-2012-302092. PubMed DOI

NG CW, JIANG AA, TOH EMS, NG CH, ONG ZH, PENG S, THAM HY, SUNDAR R, CHONG CS, KHOO CM. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression. Int J Colorectal Dis. 2020;35:1501–1512. doi: 10.1007/s00384-020-03676-x. PubMed DOI

PABST O. Correlation, consequence, and functionality in microbiome-immune interplay. Immunol Rev. 2017;279:4–7. doi: 10.1111/imr.12584. PubMed DOI

PANDIT R, BEERENS S, ADAN RAH. Role of leptin in energy expenditure: the hypothalamic perspective. Am J Physiol Regul Integr Comp Physiol. 2017;312:R938–R947. doi: 10.1152/ajpregu.00045.2016. PubMed DOI

PEILA R, ROHAN TE. Diabetes, glycated hemoglobin, and risk of cancer in the UK biobank study. Cancer Epidemiol Biomarkers Prev. 2020;29:1107–1119. doi: 10.1158/1055-9965.EPI-19-1623. PubMed DOI

PHILIPPA C, MIROIU R, SLEVIN M, PETCU E. An update on angiogenesis modulators with a potential therapeutic role. Vascular Cell. 2018;10 doi: 10.24238/13221-10-1-179. DOI

PLAZA-DIAZ J, GOMEZ-LLORENTE C, FONTANA L, GIL A. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics. World J Gastroenterol. 2014;20:15632–15649. doi: 10.3748/wjg.v20.i42.15632. PubMed DOI PMC

POTTER M, NEWPORT E, MORTEN KJ. The Warburg effect: 80 years on. Biochem Soc Trans. 2016;44:1499–1505. doi: 10.1042/BST20160094. PubMed DOI PMC

QI L, CHEN J, YANG Y, HU W. Hypoxia correlates with poor survival and M2 macrophage infiltration in colorectal cancer. Front Oncol. 2020;10:566430. doi: 10.3389/fonc.2020.566430. PubMed DOI PMC

QIN J, LI R, RAES J, ARUMUGAM M, BURGDORF KS, MANICHANH C, NIELSEN T, PONS N, LEVENEZ F, YAMADA T, MENDE DR, LI J, XU J, LI S, LI D, CAO J, WANG B, LIANG H, ZHENG H, XIE Y, TAP J, LEPAGE P, BERTALAN M, BATTO JM, HANSEN T, LE PASLIER D, LINNEBERG A, NIELSEN HB, PELLETIER E, RENAULT P, SICHERITZ-PONTEN T, TURNER K, ZHU H, YU C, LI S, JIAN M, ZHOU Y, LI Y, ZHANG X, LI S, QIN N, YANG H, WANG J, BRUNAK S, DORÉ J, GUARNER F, KRISTIANSEN K, PEDERSEN O, PARKHILL J, WEISSENBACH J, METAHIT CONSORTIUM, BORK P, EHRLICH SD, WANG J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65. doi: 10.1038/nature08821. PubMed DOI PMC

RAMOS A, HEMANN MT. Drugs, bugs, and cancer: Fusobacterium nucleatum promotes chemoresistance in colorectal cancer. Cell. 2017;170:411–413. doi: 10.1016/j.cell.2017.07.018. PubMed DOI

RAMTEKE P, DEB A, SHEPAL V, BHAT MK. Hyperglycemia associated metabolic and molecular alterations in cancer risk, progression, treatment, and mortality. Cancers (Basel) 2019;11:1402. doi: 10.3390/cancers11091402. PubMed DOI PMC

RAO KONDAPALLY SESHASAI S, KAPTOGE S, THOMPSON A, DI ANGELANTONIO E, GAO P, SARWAR N, WHINCUP PH, MUKAMAL KJ, GILLUM RF, HOLME I, NJØLSTAD I, FLETCHER A, NILSSON P, LEWINGTON S, COLLINS R, GUDNASON V, THOMPSON SG, SATTAR N, SELVIN E, HU FB, DANESH J EMERGING RISK FACTORS COLLABORATION. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364:829–841. doi: 10.1056/NEJMoa1008862. PubMed DOI PMC

REIMER RA, GROVER GJ, KOETZNER L, GAHLER RJ, LYON MR, WOOD S. Combining sitagliptin/metformin with a functional fiber delays diabetes progression in Zucker rats. J Endocrinol. 2014;220:361–373. doi: 10.1530/JOE-13-0484. PubMed DOI

RENEHAN AG, ZWAHLEN M, EGGER M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer. 2015;15:484–98. doi: 10.1038/nrc3967. PubMed DOI

RIONDINO S, ROSELLI M, PALMIROTTA R, DELLA-MORTE D, FERRONI P, GUADAGNI F. Obesity and colorectal cancer: role of adipokines in tumor initiation and progression. World J Gastroenterol. 2014;20:5177–5190. doi: 10.3748/wjg.v20.i18.5177. PubMed DOI PMC

ROJAS A, AÑAZCO C, GONZÁLEZ I, ARAYA P. Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer. Carcinogenesis. 2018;39:515–521. doi: 10.1093/carcin/bgy012. PubMed DOI

SAMAD N, RAO T. Role of leptin in cancer: A systematic review. Biomed J Sci Tech Res. 2019;18:13226–13235. doi: 10.26717/BJSTR.2019.18.003091. DOI

SCALIA P, GIORDANO A, WILLIAMS SJ. The IGF-II-Insulin Receptor Isoform-A autocrine signal in cancer: actionable perspectives. Cancers (Basel) 2020;12:366. doi: 10.3390/cancers12020366. PubMed DOI PMC

SCHRÖTER D, HÖHN A. Role of advanced glycation end products in carcinogenesis and their therapeutic implications. Curr Pharm Des. 2018;24:5245–5251. doi: 10.2174/1381612825666190130145549. PubMed DOI PMC

SEDIGHI M, RAZAVI S, NAVAB-MOGHADAM F, KHAMSEH ME, ALAEI-SHAHMIRI F, MEHRTASH A, AMIRMOZAFARI N. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals. Microb Pathog. 2017;111:362–369. doi: 10.1016/j.micpath.2017.08.038. PubMed DOI

SHEN XJ, RAWLS JF, RANDALL T, BURCAL L, MPANDE CN, JENKINS N, JOVOV B, ABDO Z, SANDLER RS, KEKU TO. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes. 2010;1:138–147. doi: 10.4161/gmic.1.3.12360. PubMed DOI PMC

SHI J, FAN J, SU Q, YANG Z. Cytokines and abnormal glucose and lipid metabolism. Front Endocrinol (Lausanne) 2019;10:703. doi: 10.3389/fendo.2019.00703. PubMed DOI PMC

SHI J, XIONG L, LI J, CAO H, JIANG W, LIU B, CHEN X, LIU C, LIU K, WANG G, CAI K. A linear dose-response relationship between fasting plasma glucose and colorectal cancer risk: systematic review and meta-analysis. Sci Rep. 2015;5:17591. doi: 10.1038/srep17591. PubMed DOI PMC

SHIN S, EL-SABBAGH AS, LUKAS BE, TANNEBERGER SJ, JIANG Y. Adipose stem cells in obesity: challenges and opportunities. Biosci Rep. 2020;40:BSR20194076. doi: 10.1042/BSR20194076. PubMed DOI PMC

SIMPSON A, PETNGA W, MACAULAY VM, WEYER-CZERNILOFSKY U, BOGENRIEDER T. Insulin-like Growth Factor (IGF) pathway targeting in cancer: Role of the IGF axis and opportunities for future combination studies. Target Oncol. 2017;12:571–597. doi: 10.1007/s11523-017-0514-5. PubMed DOI PMC

ŠKRHA J, JR, MURAVSKÁ A, FLEKAČ M, HOROVÁ E, NOVÁK J, NOVOTNÝ A, PRÁZNÝ M, ŠKRHA J, KVASNIČKA J, LANDOVÁ L, JÁCHYMOVÁ M, ZIMA T, KALOUSOVÁ M. Fructosamine 3-kinase and glyoxalase I polymorphisms and their association with soluble RAGE and adhesion molecules in diabetes. Physiol Res. 2014;63(Suppl 2):S283–S291. doi: 10.33549/physiolres.932790. PubMed DOI

STENMAN LK, WAGET A, GARRET C, BRIAND F, BURCELIN R, SULPICE T, LAHTINEN S. Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice. Diabetol Metab Syndr. 2015;7:75. doi: 10.1186/s13098-015-0075-7. PubMed DOI PMC

STOLARCZYK E. Adipose tissue inflammation in obesity: a metabolic or immune response? Curr Opin Pharmacol. 2017;37:35–40. doi: 10.1016/j.coph.2017.08.006. PubMed DOI

SUCHANEK S, GREGA T, NGO O, VOJTECHOVA G, MAJEK O, MINARIKOVA P, BROGYUK N, BUNGANIC B, SEIFERT B, DUSEK L, ZAVORAL M. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol. 2016;22:8103–8111. doi: 10.3748/wjg.v22.i36.8103. PubMed DOI PMC

THOMAS D, APOVIAN C. Macrophage functions in lean and obese adipose tissue. Metabolism. 2017;72:120–143. doi: 10.1016/j.metabol.2017.04.005. PubMed DOI PMC

URBANCSEK H, KAZAR T, MEZES I, NEUMANN K. Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol. 2001;13:391–396. doi: 10.1097/00042737-200104000-00015. PubMed DOI

URBANOVA M, MRAZ M, DUROVCOVA V, TRACHTA P, KLOUCKOVÁ J, KAVALKOVA P, HALUZIKOVA D, LACINOVA Z, HANSIKOVA H, WENCHICH L, KRSEK M, HALUZIK M. The effect of very-low-calorie diet on mitochondrial dysfunction in subcutaneous adipose tissue and peripheral monocytes of obese subjects with type 2 diabetes mellitus. Physiol Res. 2017;66:811–822. doi: 10.33549/physiolres.933469. PubMed DOI

VELLA V, MILLUZZO A, SCALISI NM, VIGNERI P, SCIACCA L. Insulin Receptor Isoforms in Cancer. Int J Mol Sci. 2018;19:3615. doi: 10.3390/ijms19113615. PubMed DOI PMC

WANG N, KHANKARI NK, CAI H, LI HL, YANG G, GAO YT, XIANG YB, SHU XO, ZHENG W. Prediagnosis body mass index and waist-hip circumference ratio in association with colorectal cancer survival. Int J Cancer. 2017;140:292–301. doi: 10.1002/ijc.30459. PubMed DOI PMC

XU J, YE Y, WU H, DUERKSEN-HUGHES P, ZHANG H, LI P, HUANG J, YANG J, WU Y, XIA D. Association between markers of glucose metabolism and risk of colorectal cancer. BMJ Open. 2016;6:e011430. doi: 10.1136/bmjopen-2016-011430. PubMed DOI PMC

YOON KW, PARK SY, KIM JY, LEE SM, PARK CH, CHO SB, LEE WS, JOO YE, LEE JH, KIM HS, CHOI SK, REW JS. Leptin-induced adhesion and invasion in colorectal cancer cell lines. Oncol Rep. 2014;31:2493–8. doi: 10.3892/or.2014.3128. PubMed DOI

ZELENKO Z, GALLAGHER EJ. Diabetes and cancer. Endocrinol Metab Clin North Am. 2014;43:167–85. doi: 10.1016/j.ecl.2013.09.008. PubMed DOI

ZHENG J, CHEN S, ALBIERO ML, VIEIRA GHA, WANG J, FENG JQ, GRAVES DT. Diabetes activates periodontal ligament fibroblasts via NF-κB in vivo. J Dent Res. 2018;97:580–588. doi: 10.1177/0022034518755697. PubMed DOI PMC

ZHU B, WU X, WU B, PEI D, ZHANG L, WEI L. The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies. PLoS One. 2017;12:e0176068. doi: 10.1371/journal.pone.0176068. PubMed DOI PMC

ZIŃCZUK J, MACIEJCZYK M, ZARĘBA K, ROMANIUK W, MARKOWSKI A, KĘDRA B, ZALEWSKA A, PRYCZYNICZ A, MATOWICKA-KARNA J, GUZIŃSKA-USTYMOWICZ K. Antioxidant barrier, redox status, and oxidative damage to biomolecules in patients with colorectal cancer. Can malondialdehyde and catalase be markers of colorectal cancer advancement? Biomolecules. 2019;9:637. doi: 10.3390/biom9100637. PubMed DOI PMC

ZITVOGEL L, GALLUZZI L, VIAUD S, VÉTIZOU M, DAILLÈRE R, MERAD M, KROEMER G. Cancer and the gut microbiota: an unexpected link. Sci Transl Med. 2015;7:271ps1. doi: 10.1126/scitranslmed.3010473. PubMed DOI PMC

Type 2 Diabetes, Obesity and Their Relation to the Risks of Thyroid Cancer

Serological markers of intestinal barrier impairment do not correlate with duration of diabetes and glycated hemoglobin in adult patients with type 1 and type 2 diabetes mellitus